The place of metoprolol tartrate in the treatment of cardiovascular diseases
Since the beginning of the 1960s, beta-blockers have been number one medications in the treatment of cardiovascular diseases. A number of randomized controlled trials (RCTs) demonstrated positive effect of beta-blockers on morbidity and mortality [1]. It is difficult to overestimate the role of beta...
Main Authors: | N. V. Romanova, I. V. Zhirov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2016-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/71 |
Similar Items
-
Metoprolol tartrate. Сlinical use
by: A. A. Zateischikova
Published: (2015-12-01) -
TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE
by: O. D. Ostroumova, et al.
Published: (2015-12-01) -
COMPARISON BETAXOLOL AND METOPROLOL TARTRATE THERAPIES IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH STABLE ANGINA
by: A. A. Anderzhanova, et al.
Published: (2016-01-01) -
TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION 1-2 GRADE WITH METOPROLOL TARTRATE AND ANALYSIS OF HEART RATE VARIABILITY
by: V. E. Oleinikov, et al.
Published: (2015-12-01) -
USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES?
by: V. V. Samoylenko, et al.
Published: (2015-09-01)